Variant report
Variant | esv19436 |
---|---|
Chromosome Location | chr10:25905114-25905885 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560222856 | chr10:25905126-25905127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535054396 | chr10:25905143-25905144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563846307 | chr10:25905147-25905148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185425779 | chr10:25905230-25905231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs578261274 | chr10:25905231-25905232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537727944 | chr10:25905238-25905239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370085929 | chr10:25905261-25905262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12771005 | chr10:25905283-25905284 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs12763829 | chr10:25905323-25905324 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs7477188 | chr10:25905340-25905341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372522231 | chr10:25905343-25905344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75018917 | chr10:25905379-25905380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190674648 | chr10:25905380-25905381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140249040 | chr10:25905402-25905403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563181827 | chr10:25905412-25905413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs12765442 | chr10:25905421-25905422 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs552073588 | chr10:25905422-25905423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570416411 | chr10:25905552-25905553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559854980 | chr10:25905568-25905569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564530881 | chr10:25905580-25905581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs11596434 | chr10:25905644-25905645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530723666 | chr10:25905651-25905652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2001385 | chr10:25905668-25905669 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs2095456 | chr10:25905674-25905675 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs868692 | chr10:25905810-25905811 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs573363343 | chr10:25905833-25905834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs868691 | chr10:25905876-25905877 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 21439084 | CNVD |
Maculopathy | 20981449 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:25904600-25906000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
2 | chr10:25904800-25905200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr10:25904800-25905200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr10:25904800-25906200 | Enhancers | Skeletal Muscle Female | skeletal muscle |